Blockchain Registration Transaction Record

K2 Laboratory Milestone: NDC Numbers Obtained for Investigational Drugs

K2 Laboratory achieves milestone with NDC numbers for Brain Rehabilitation and Telomerase Inhibitor oral solutions, marking progress in Alzheimer's disease and cancer research.

K2 Laboratory Milestone: NDC Numbers Obtained for Investigational Drugs

This news matters as it showcases the progress in pharmaceutical research, particularly in the areas of Alzheimer's disease and cancer studies. It demonstrates K2 Laboratory's dedication to advancing medical innovation and potentially providing new treatment options in the future.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0x7014b7d85cb0cddf3ac6b46321ea2dfd53aa9bc1c0fb5e9541795e54c0f96100
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintwamcUJ1P-8548f16814675da16e1c928dd773c101